Preparation for a pneumococcal vaccine trial in The Gambia

Individual or community randomisation?

Shabbar Jaffar, Amanda Leach, Andrew J. Hall, Stephen K Obaro, Keith P.W.J. McAdam, Peter G. Smith, Brian M. Greenwood

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In preparation for a large phase-3 trial of pneumococcal polysaccharide/conjugate vaccine among infants in The Gambia, the relative merits of community and individual randomisation were considered. The impact of vaccination might be enhanced in a community randomised trial if there was a substantial 'herd' effect. This might occur if those vaccinated comprise a substantial proportion of potential transmitters of infection. However, there are few data on the sources of pneumococcal infections in The Gambia and with the high degree of mobility of people in The Gambia, it seems unlikely that any herd effect would be strong. In the absence of a herd effect, a community-randomised trial would have lower power for the mortality end- points compared to an individually randomised trial of the same size. In addition, a community-randomised trial might not provide sufficient control against potential confounders and blinding might be difficult to sustain if the vaccine has a strong effect. An individually randomised trial seems a better strategy under the conditions prevailing in The Gambia.

Original languageEnglish (US)
Pages (from-to)633-640
Number of pages8
JournalVaccine
Volume18
Issue number7-8
DOIs
StatePublished - Nov 12 1999

Fingerprint

Gambia
Pneumococcal Vaccines
Random Allocation
vaccines
herds
Pneumococcal Infections
Conjugate Vaccines
Information Storage and Retrieval
infection
Vaccination
polysaccharides
Vaccines
vaccination
Mortality
Infection

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Jaffar, S., Leach, A., Hall, A. J., Obaro, S. K., McAdam, K. P. W. J., Smith, P. G., & Greenwood, B. M. (1999). Preparation for a pneumococcal vaccine trial in The Gambia: Individual or community randomisation? Vaccine, 18(7-8), 633-640. https://doi.org/10.1016/S0264-410X(99)00277-7

Preparation for a pneumococcal vaccine trial in The Gambia : Individual or community randomisation? / Jaffar, Shabbar; Leach, Amanda; Hall, Andrew J.; Obaro, Stephen K; McAdam, Keith P.W.J.; Smith, Peter G.; Greenwood, Brian M.

In: Vaccine, Vol. 18, No. 7-8, 12.11.1999, p. 633-640.

Research output: Contribution to journalArticle

Jaffar, S, Leach, A, Hall, AJ, Obaro, SK, McAdam, KPWJ, Smith, PG & Greenwood, BM 1999, 'Preparation for a pneumococcal vaccine trial in The Gambia: Individual or community randomisation?', Vaccine, vol. 18, no. 7-8, pp. 633-640. https://doi.org/10.1016/S0264-410X(99)00277-7
Jaffar, Shabbar ; Leach, Amanda ; Hall, Andrew J. ; Obaro, Stephen K ; McAdam, Keith P.W.J. ; Smith, Peter G. ; Greenwood, Brian M. / Preparation for a pneumococcal vaccine trial in The Gambia : Individual or community randomisation?. In: Vaccine. 1999 ; Vol. 18, No. 7-8. pp. 633-640.
@article{84351f03f7d44d6ba5e0dafdb466faa3,
title = "Preparation for a pneumococcal vaccine trial in The Gambia: Individual or community randomisation?",
abstract = "In preparation for a large phase-3 trial of pneumococcal polysaccharide/conjugate vaccine among infants in The Gambia, the relative merits of community and individual randomisation were considered. The impact of vaccination might be enhanced in a community randomised trial if there was a substantial 'herd' effect. This might occur if those vaccinated comprise a substantial proportion of potential transmitters of infection. However, there are few data on the sources of pneumococcal infections in The Gambia and with the high degree of mobility of people in The Gambia, it seems unlikely that any herd effect would be strong. In the absence of a herd effect, a community-randomised trial would have lower power for the mortality end- points compared to an individually randomised trial of the same size. In addition, a community-randomised trial might not provide sufficient control against potential confounders and blinding might be difficult to sustain if the vaccine has a strong effect. An individually randomised trial seems a better strategy under the conditions prevailing in The Gambia.",
author = "Shabbar Jaffar and Amanda Leach and Hall, {Andrew J.} and Obaro, {Stephen K} and McAdam, {Keith P.W.J.} and Smith, {Peter G.} and Greenwood, {Brian M.}",
year = "1999",
month = "11",
day = "12",
doi = "10.1016/S0264-410X(99)00277-7",
language = "English (US)",
volume = "18",
pages = "633--640",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "7-8",

}

TY - JOUR

T1 - Preparation for a pneumococcal vaccine trial in The Gambia

T2 - Individual or community randomisation?

AU - Jaffar, Shabbar

AU - Leach, Amanda

AU - Hall, Andrew J.

AU - Obaro, Stephen K

AU - McAdam, Keith P.W.J.

AU - Smith, Peter G.

AU - Greenwood, Brian M.

PY - 1999/11/12

Y1 - 1999/11/12

N2 - In preparation for a large phase-3 trial of pneumococcal polysaccharide/conjugate vaccine among infants in The Gambia, the relative merits of community and individual randomisation were considered. The impact of vaccination might be enhanced in a community randomised trial if there was a substantial 'herd' effect. This might occur if those vaccinated comprise a substantial proportion of potential transmitters of infection. However, there are few data on the sources of pneumococcal infections in The Gambia and with the high degree of mobility of people in The Gambia, it seems unlikely that any herd effect would be strong. In the absence of a herd effect, a community-randomised trial would have lower power for the mortality end- points compared to an individually randomised trial of the same size. In addition, a community-randomised trial might not provide sufficient control against potential confounders and blinding might be difficult to sustain if the vaccine has a strong effect. An individually randomised trial seems a better strategy under the conditions prevailing in The Gambia.

AB - In preparation for a large phase-3 trial of pneumococcal polysaccharide/conjugate vaccine among infants in The Gambia, the relative merits of community and individual randomisation were considered. The impact of vaccination might be enhanced in a community randomised trial if there was a substantial 'herd' effect. This might occur if those vaccinated comprise a substantial proportion of potential transmitters of infection. However, there are few data on the sources of pneumococcal infections in The Gambia and with the high degree of mobility of people in The Gambia, it seems unlikely that any herd effect would be strong. In the absence of a herd effect, a community-randomised trial would have lower power for the mortality end- points compared to an individually randomised trial of the same size. In addition, a community-randomised trial might not provide sufficient control against potential confounders and blinding might be difficult to sustain if the vaccine has a strong effect. An individually randomised trial seems a better strategy under the conditions prevailing in The Gambia.

UR - http://www.scopus.com/inward/record.url?scp=0032736845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032736845&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(99)00277-7

DO - 10.1016/S0264-410X(99)00277-7

M3 - Article

VL - 18

SP - 633

EP - 640

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 7-8

ER -